India's preferred Personal finance destination
Home Shares F&O Mutual Funds IPO Commodity Portfolio Financial Planning Insurance Loans News Centre About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker Newsletter Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ntpc Ltd 150.25 1.08
Tata Stl 313.15 4.56
State Ba 2151.15 1.15
Tata Mot 288.10 0.93
Hindalco 107.10 1.70
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
 
News-Sanofi India Limited
Sanofi India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500674NSE:SANOFIBloomberg:AVEN@INReuters:AVPH.BO
Market Lot: 1Face Value: 10ISIN Demat: INE058A01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
15-Feb-2013       Sanofi India rallies after HC ruling on Shantha-tax case IRIS
15-Feb-2013       Sanofi will not have to pay tax in India, rules HC IRIS
24-Feb-2012       `Sell` Aventis; target Rs 1,937: Angel Broking IRIS Exclusive
23-Feb-2012       Aventis Pharma Q4 profit drops 66% IRIS
04-Nov-2011       Aventis Pharma completes acquisition of Universal Medicare IRIS
24-Aug-2011       Aventis Pharma up on acquisition news IRIS
24-Aug-2011       Aventis Pharma to acquire Universal Medicare`s nutraceutical unit IRIS
01-Aug-2011       Motilal Oswal maintains `Neutral` on Aventis Pharma  IRIS Exclusive
29-Jul-2011       Angel Broking maintains `Reduce` on Aventis Pharma  IRIS Exclusive
27-Apr-2011       Aventis Pharma earnings jump 40.17% for Mar`11 qtr IRIS
13-Dec-2010       Aventis Pharma exits JV with Novartis Pharma IRIS
28-Oct-2010       Aventis Pharma profit rises 7.99% for Sep`10 qtr IRIS
25-Oct-2010       Angel recommends `Reduce` on Aventis Pharma IRIS Exclusive
20-Jul-2010       Angel Broking recommends `Sell` on Aventis Pharma IRIS Exclusive
19-Jul-2010       Aventis Pharma Q1 net dips 10% IRIS
19-Jul-2010       Aventis Pharma to post 10.30% rise in Q2 net sales: Angel IRIS

 

 

Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
© All rights reserved. IRIS Business Services Limited
Disclaimer